Canada· CA-DIN-02246162
REACTINE COMPLETE
A pseudoephedrin, kombinationen product containing cetirizine hydrochloride + pseudoephedrine hydrochloride, registered in Canada by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Pseudoephedrin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC R01BA52 (pseudoephedrin, kombinationen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Pseudoephedrin, kombinationen · ATC R01BA52
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of pseudoephedrin, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pseudoephedrin, kombinationen · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CETIRIZINE HYDROCHLORIDE + PSEUDOEPHEDRINE HYDROCHLORIDE
- Manufacturer
- MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
- Country
- Canada (CA)
- ATC code
- R01BA52
- ATC class
- Pseudoephedrin, Kombinationen
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for pseudoephedrin, kombinationen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pseudoephedrin, kombinationen · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Pseudoephedrin, kombinationen in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCirrusDelfarma Sp. z o.o.
- United StatesAllergy Relief-DCVS PHARMACY
- SpainREACTINE CETIRIZINA/PSEUDOEFEDRINA 5mg/120mg COMPRIMIDOS DE LIBERACION PROLONGADAJntl Consumer Health (Spain) S.L.
- FinlandCirrusOrifarm Oy
- GermanyReactine DuoKenvue Germany Gmbh
- IrelandZirtek Plus Decongestant 5mg/120mg Prolonged Release TabletUCB (Pharma) Ireland Limited,
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Cirrus, Rhinosinutab
- Bulgaria · Зиртек-D
- Germany · Reactine Duo
- Estonia · Cirrus
- Spain · Reactine, Respidina Antialérgica
- Hungary · Zyrtec-D
- Ireland · Zirtek Plus Decongestant
- Italy · Reactine, Zirtec Decongestionante Antistaminico
- Lithuania · Cirrus
- Luxembourg · Cirrus, Rhinosinutab
- Latvia · Cirrus
- Malta · Cirrus
- Poland · Cirrus, Cirrus Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/164eaeb8-c440-4463-88c9-2ee24d71a5fd GET /v1/drugs/164eaeb8-c440-4463-88c9-2ee24d71a5fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02246162",
"form": "TABLET (EXTENDED-RELEASE)",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R01BA52",
"schedule": [
"OTC"
],
"drug_code": "70312",
"strengths": [
"5 MG",
"120 MG"
],
"ahfs_class": null,
"substances": [
"CETIRIZINE HYDROCHLORIDE",
"PSEUDOEPHEDRINE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about pseudoephedrin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.